Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for hospitalized adults with COVID-19 requiring oxygen
ISRCTN60069084Phase 4Completed
- Sponsor
- King Saud Medical City
- Start
- Sep 2020
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing N-acetylcysteine + standard of care with Placebo + standard of care (2 arms). Primary endpoint: Time to recovery. Started Sep 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN60069084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN60069084.